0 of 15 Questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 15 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
What is the primary focus of this study?
1
Which opioid class is identified as one of the fastest-growing in the emergency department?
1
What was the primary outcome measured in the study?
2
What were the common drugs detected in the novel potent opioid overdoses?
1
What is the potency of nitazenes compared to morphine?
2
What percentage of patients with metonitazene overdoses experienced cardiac arrest?
2
How did the naloxone doses for NPO overdoses compare to those for fentanyl overdoses?
2
Which NPO was most associated with severe clinical toxicity in the study?
3
Which patient demographic was most affected by novel potent opioids in this study?
3
What public health threat do novel potent opioids present according to the article?
3
True or False: Metonitazene is chemically related to fentanyl.
2
True or False: Naloxone is ineffective against NPO overdoses.
2
True or False: All patients with brorphine overdose required naloxone.
5
What is the potential outcome for patients using NPOs like metonitazene?
5
How do public health agencies view the rise of NPOs in the drug market?
3
If you would like to know more about our INRAsafe Accredited Courses please contact us below